Grant: Operating Grant: Industry-partnered Collaborative Research - Rx&D partner
University of Toronto
$193,701.00
Metabotropic Glutamate and GABA Receptors in Neuroinflammation
FY 2010-11
Summary
Some scientists have proposed that several neurological and neuropsychiatric disorders, such as schizophrenia and autism spectrum disorders, are associated with an immune reaction in the brain. One group of neurotransmitter receptors, called the metabotropic glutamate receptors, might be involved in this CNS immune response in these disorders. This study will investigate whether or not manipulating the immune system affects the amounts and activity of the glutamate receptors, and conversely, whether altering the receptors has effects on the immune system. These experiments will be conducted on mice and cells in culture. The long-term goal of this work is to ascertain whether pharmacological intervention would be justified in treating the human disorders.
Department
Program
Operating Grant: Industry-partnered Collaborative Research - Rx&D partner
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
234414
Name
Hampson David R
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Industry Partnered Collaborative Research
Projecttitle
Metabotropic Glutamate and GABA Receptors in Neuroinflammation
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$193,701
Cihrequipment2
$4,785
Programname2
Operating Grant: Industry-partnered Collaborative Research - Rx&D partner
Keyworddelim
Astrocytes; Cerebellum; Cytokines; Glia; Glutamate; Hyperactivity; Metabotropic Glutamate; Microglia; Neuroinflammation; Seizures
Abstract
Some scientists have proposed that several neurological and neuropsychiatric disorders, such as schizophrenia and autism spectrum disorders, are associated with an immune reaction in the brain. One group of neurotransmitter receptors, called the metabotropic glutamate receptors, might be involved in this CNS immune response in these disorders. This study will investigate whether or not manipulating the immune system affects the amounts and activity of the glutamate receptors, and conversely, whether altering the receptors has effects on the immune system. These experiments will be conducted on mice and cells in culture. The long-term goal of this work is to ascertain whether pharmacological intervention would be justified in treating the human disorders.
Competitiondate
201103
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Hampson, David R
Approvedterm
3 ans 0 mois
Cihrcontribution2
Patient Oriented Research~ $193,701~ $4,785~